Biologic monotherapy versus combination therapy with immunomodulators in the induction and maintenance of remission of Crohn’s disease and ulcerative colitis

Despite current guidelines, the optimal treatment of patients with inflammatory bowel disease (IBD) remains challenging. The available medications are not without risk and there is not a single correct treatment regimen for every patient. Personalizing treatment and selecting the most appropriate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashash, Jana G., Fadel, Carla G. Abou, Rimmani, Hussein H., Sharara, Ala I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375659/
https://www.ncbi.nlm.nih.gov/pubmed/34475731
http://dx.doi.org/10.20524/aog.2021.0645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375659/
https://www.ncbi.nlm.nih.gov/pubmed/34475731
http://dx.doi.org/10.20524/aog.2021.0645

Ejemplares similares